iCAD Reports Fourth Quarter and Full Year 2007 Financi...(uncertainty of patent protection the imp...),Health

Date:3/6/2008

uncertainty of patent protection, the impact of supply and manufacturing constraints or difficulties, product market acceptance, possible technological obsolescence, increased competition, customer concentration and other risks detailed in the Company's filings with the Securities and Exchange Commission. The words "believe", "demonstrate", "intend", "expect", "estimate", "anticipate", "likely", and similar expressions identify forward- looking statements. Readers are cautioned not to place undue reliance on those forward-looking statements, which speak only as of the date the statement was made. The Company is under no obligation to provide any updates to any information contained in this release.

iCAD, Inc.

Condensed Consolidated Statements of Operations

(unaudited)

Three Months Ended Twelve Months Ended

December 31, December 31,

2007 2006 2007 2006

Revenue $8,100,649 $6,439,679 $26,612,412 $19,721,358

Cost of revenue 1,582,278 1,340,357 5,257,104 4,290,818

Gross margin 6,518,371 5,099,322 21,355,308 15,430,540

Gross margin % 80.5% 79.2% 80.2% 78.2%

Operating expenses:

Engineering and

product development 1,176,356 1,410,110 4,504,000 5,260,893

Marketing and sales 2,857,272 3,161,485 10,780,304 9,228,881

General and

administrative 1,854,844 1,803,179 7,174,807 7,379,445

Total operating

expenses 5,888,472 6,374,774 22,459,111 21,869,219

Income (loss) from

operations 629,899 (1,275,452) (1,103,803) (6,438,679)

Interest expense - net 104,838
'/>"/>

SOURCE iCAD, Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9
Related medicine news :

1. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
2. Haemacure Reports Third Quarter 2007 Results
3. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
4. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
5. MDS Reports Third Quarter 2007 Results
6. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
7. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
8. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
9. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
10. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
11. AdCare Health Systems, Inc. Reports Discontinuation of Definitive Merger Agreement with Family Home Health Services, Inc.